{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Free Dermal Fat Graft and Superficial Musculoaponeurotic System Flap in Superficial Parotidectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Sample size was calculated to detect differences in Frey\u2019s syndrome incidence with 80% power and a 5% significance level."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a single centre, this prospective study included 78 adult patients undergoing superficial conservative parotidectomy for benign indications."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised into two equal groups using a closed envelope method: one group received FDFG, and the other received SMAS flap."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to compare the effectiveness of free dermal fat graft (FDFG) and superficial musculoaponeurotic system (SMAS) flap in reducing these complications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the development of Frey\u2019s syndrome, assessed at 6 months postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was concealed, and outcome assessors were blinded."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Randomisation was concealed, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between February 2016 and October 2021, 78 patients were randomised equally."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "78 patients were randomised equally."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "There was no significant difference in the incidence of Frey\u2019s syndrome between the FDFG and SMAS groups."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were minimal, with mild infection and seroma occurring only in the FDFG group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT05452837."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}